Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ji-Yong Moon, Fernando Sergio Leitao Filho, Kimeya Shahangian, Hiroto Takiguchi & Don D. Sin. (2018) Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD). Expert Review of Proteomics 15:11, pages 923-935.
Read now
Read now
David G Parr & Beatriz Lara. (2017) Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature. Drug Design, Development and Therapy 11, pages 2149-2162.
Read now
Read now
Alessandro N Franciosi, Cormac McCarthy & Noel Gerry McElvaney. (2015) The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema. Expert Review of Respiratory Medicine 9:2, pages 143-151.
Read now
Read now
James K. Stoller. (2013) Elastin Degradation Products as Biomarkers in Alpha-1 Antitrypsin Deficiency: Lastin’ Impact?. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:4, pages 403-404.
Read now
Read now
Articles from other publishers (26)
Igor Barjaktarevic & Michael Campos. (2021) Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know. Therapeutic Advances in Chronic Disease 12_suppl, pages 204062232110101.
Crossref
Crossref
Noriko M. Matsumoto, Masayo Aoki, Yuri Okubo, Kosuke Kuwahara, Shigeyoshi Eura, Teruyuki Dohi, Satoshi Akaishi & Rei Ogawa. (2020) Gene Expression Profile of Isolated Dermal Vascular Endothelial Cells in Keloids. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Michael E O'Brien, Laura Fee, Niall Browne, Tomás P Carroll, Paula Meleady, Michael Henry, Karen McQuillan, Mark P Murphy, Mark Logan, Cormac McCarthy, Oliver J McElvaney, Emer P Reeves & Noel G McElvaney. (2020) Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency. Thorax 75:4, pages 321-330.
Crossref
Crossref
Alessandro N Franciosi, Tomás P Carroll & Noel G McElvaney. (2019) Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians. The Lancet Respiratory Medicine 7:12, pages 1059-1067.
Crossref
Crossref
Michael A. Campos, Patrick Geraghty, Gregory Holt, Eliana Mendes, Paul R. Newby, Shuren Ma, Landy V. Luna-Diaz, Gerard M. Turino & Robert A. Stockley. (2019) The Biological Effects of Double-Dose Alpha-1 Antitrypsin Augmentation Therapy. A Pilot Clinical Trial. American Journal of Respiratory and Critical Care Medicine 200:3, pages 318-326.
Crossref
Crossref
Shuren Ma, Patrick Geraghty, Abdoulaye Dabo, Cormac McCarthy, N. Gerry McElvaney & Gerard M. Turino. (2019) Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation. ERJ Open Research 5:2, pages 00250-2018.
Crossref
Crossref
A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira & L. Telo. (2018) Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 24, pages 1-21.
Crossref
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2018) Tratamiento aumentativo para el enfisema por déficit de alfa-1 antitripsina: Pro. Archivos de Bronconeumología 54:7, pages 363-364.
Crossref
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2018) Augmentation Therapy for Emphysema due to Alpha-1 Antitrypsin Deficiency: Pro. Archivos de Bronconeumología (English Edition) 54:7, pages 363-364.
Crossref
Crossref
Gerard M. Turino. (2018) Chronic Obstructive Pulmonary Disease. A Biomarker and a Potential Therapy. Annals of the American Thoracic Society 15:Supplement_1, pages S15-S17.
Crossref
Crossref
Dieter Köhler. (2017) Alpha-1-Antitrypsin-Mangel: Ist die Substitution ein Mythos?. Deutsches Ärzteblatt Online.
Crossref
Crossref
Ruth Minkin, Gagangeet Sandhu, Horiana Grosu, Lori Tartell, Shuren Ma, Yong Y. Lin, Edward Eden & Gerard M. Turino. (2017) Desmosine and Isodesmosine as a Novel Biomarker for Pulmonary Arterial Hypertension: A Pilot Study. American Journal of Therapeutics 24:4, pages e399-e404.
Crossref
Crossref
Simona Viglio, Monica Di Venere, Maddalena Cagnone, Marco Fumagalli & Paolo Iadarola. 2017. Amino Acid - New Insights and Roles in Plant and Animal. Amino Acid - New Insights and Roles in Plant and Animal.
Michael Campos & Jorge Lascano. 2017. Alpha-1 Antitrypsin Deficiency. Alpha-1 Antitrypsin Deficiency
249
262
.
Umur Hatipoğlu & James K. Stoller. (2016) α1-Antitrypsin Deficiency. Clinics in Chest Medicine 37:3, pages 487-504.
Crossref
Crossref
Gerard M. Turino, Shuren Ma, Jerome O. Cantor & Yong Y. Lin. (2016) Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 13:Supplement_4, pages S336-S340.
Crossref
Crossref
David A. Lomas. (2016) An ECLIPSE View of Alpha-1 Antitrypsin Deficiency. Annals of the American Thoracic Society 13:Supplement_4, pages S326-S331.
Crossref
Crossref
Marni A. Nenke, Mark Holmes, Wayne Rankin, John G. Lewis & David J. Torpy. (2016) Corticosteroid-binding globulin cleavage is paradoxically reduced in alpha-1 antitrypsin deficiency: Implications for cortisol homeostasis. Clinica Chimica Acta 452, pages 27-31.
Crossref
Crossref
Damian Bruce-Hickman, Catherine M. Greene & Bibek Gooptu. 2015. Controversies in COPD. Controversies in COPD
47
84
.
Francisco Casas, Ignacio Blanco, María Teresa Martínez, Ana Bustamante, Marc Miravitlles, Sergio Cadenas, José M. Hernández, Lourdes Lázaro, Esther Rodríguez, Francisco Rodríguez-Frías, María Torres & Beatriz Lara. (2015) Actualización sobre indicaciones de búsqueda activa de casos y tratamiento con alfa-1 antitripsina por vía intravenosa en pacientes con enfermedad pulmonar obstructiva crónica asociada a déficit de alfa-1 antitripsina. Archivos de Bronconeumología 51:4, pages 185-192.
Crossref
Crossref
Francisco Casas, Ignacio Blanco, María Teresa Martínez, Ana Bustamante, Marc Miravitlles, Sergio Cadenas, José M. Hernández, Lourdes Lázaro, Esther Rodríguez, Francisco Rodríguez-Frías, María Torres & Beatriz Lara. (2015) Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update. Archivos de Bronconeumología (English Edition) 51:4, pages 185-192.
Crossref
Crossref
Gabriele GrunigAram BaghdassarianSung-Hyun ParkSerhiy PylawkaBertram BleckJoan ReibmanErika Berman-RosenzweigNedim Durmus. (2016) Challenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the Lungs. Biomarker Insights 10s4, pages BMI.S29514.
Crossref
Crossref
Patrick Geraghty, Edward Eden, Manju Pillai, Michael Campos, Noel G. McElvaney & Robert F. Foronjy. (2014)
α
1
-Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses
. American Journal of Respiratory and Critical Care Medicine 190:11, pages 1229-1242.
Crossref
Crossref
Michael A. Campos & Jorge Lascano. (2014) α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy. Therapeutic Advances in Respiratory Disease 8:5, pages 150-161.
Crossref
Crossref
Simona Viglio, Jan Stolk, Maurizio Luisetti, Fabio Ferrari, Paolo Piccinini & Paolo Iadarola. (2013)
From micellar electrokinetic chromatography to liquid chromatography‐mass spectrometry:
R
evisiting the way of analyzing human fluids for the search of desmosines, putative biomarkers of chronic obstructive pulmonary disease
. ELECTROPHORESIS 35:1, pages 109-118.
Crossref
Crossref
Robert A. Stockley. (2013) Large Chronic Obstructive Pulmonary Disease Cohorts: Advantages and Caution in Biomarker Discovery/Validation. American Journal of Respiratory and Critical Care Medicine 188:12, pages 1387-1388.
Crossref
Crossref